Shell is reportedly considering selling a majority stake in its Malaysian gas-to-liquids unit, Shell MDS, as part of a review of selected assets, with a potential deal valued at around US$1,000 million. The company currently holds a 72% stake in Shell MDS, and a sale would reduce its exposure to this specialized downstream technology business. This move aligns with Shell's broader strategy to high-grade its portfolio by exiting non-core chemicals and specialty assets, redirecting capital toward higher-return areas such as LNG and deepwater projects. Investors are watching for concrete deal terms, including the size of the stake sold and the final transaction value, to gauge the impact on Shell's capital allocation priorities.
Shell plcPotential sale of majority stake in Shell MDS for ~$1B, part of portfolio high-grading; impact depends on deal terms and capital allocation.
